Junko Matsuzaki to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Junko Matsuzaki has written about Xenograft Model Antitumor Assays.
Connection Strength
0.071
-
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy. Cancer Immunol Immunother. 2021 Jul; 70(7):2073-2086.
Score: 0.043
-
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leuk Res. 2014 Nov; 38(11):1332-41.
Score: 0.028